Estramustine Phosphate: Clinical Trials

5 trials of Estramustine Phosphate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 1 unknown. 5 Phase 2, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 4, Unknown 1
Phase 12Completed 2

Follow Estramustine Phosphate: new trials by email Literature Review of Estramustine Phosphate trials Research Report on Estramustine Phosphate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluation of the Efficacy of Estramustine in Patient With Breast Cancer Progression After Treatment With Aromatase Inhibitor.
Estramustine, Tamoxifen - Breast Cancer
Phase 2CompletedInstitut de Cancérologie de Lorraine1002011-06-152020-03-09
Safety and Efficacy Study of of Docetaxel vs Docetaxel Estramustine in Hormone Refractory Prostatic Cancer
docetaxel, estramustine, prednisone - Hormone Resistant Prostate Cancer, Metastatic Prostate Cancer
Phase 2CompletedCliniques universitaires Saint-Luc- Université Catholique de Louvain1502003-12-012009-10-27
A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer
Epirubicin, Estramustine Phosphate, Celecoxib - Prostate Cancer
Phase 2UnknownDepartment of Veterans Affairs, New Jersey282002-07-012005-09-22
Study of Paclitaxel, Estramustine Phosphate and Thalidomide for Patients With Metastatic Androgen-Independent Prostate Carcinoma
Estramustine, Thalidomide, Paclitaxel (Taxol) - Prostate Cancer
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center402000-10-012018-10-31
Intravenous Estramustine With Taxol in Hormone Refractory Prostate Adenocarcinoma
Estramustine, Taxol - Prostate Cancer
Phase 1 / Phase 2CompletedM.D. Anderson Cancer Center142000-06-012012-08-01

Conditions studied

Prostatic Neoplasms (4)  ·  Neoplasm Metastasis (2)  ·  Breast Neoplasms (1)

Sponsors

M.D. Anderson Cancer Center (2)  ·  Cliniques universitaires Saint-Luc- Université Catholique de Louvain (1)  ·  Department of Veterans Affairs, New Jersey (1)  ·  Institut de Cancérologie de Lorraine (1)

Countries

United States (3)  ·  Belgium (1)  ·  France (1)  ·  Luxembourg (1)

Top investigators

Basil Kasimis, MD (1)  ·  Christopher J. Logothetis, MD (1)  ·  Jean-Pascal Machiels, MD PHD (1)  ·  Jeri Kim, M.D. (1)  ·  Joseph Kerger, MD (1)

NIH funding

2009 (1)